(Q44533984)

English

EBNA1 may prolong G(2)/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

EBNA1 may prolong G(2)/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Tzu-Chao Chuang

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Yi-Jen Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Jah-Yao Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Yen-Shing Lin

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Jhy-Wei Li

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Vinchi Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sai-Lung Law

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ming-Ching Kao

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Biochemical and Biophysical Research Communications

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

307

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

653-659

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

HER-2/neu signal transduction in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

Requirement for neuregulin receptor erbB2 in neural and cardiac development

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

neu tack on neuregulin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

Overexpression of the oncogene c-erbB-2 (HER2/neu) and response to chemotherapy in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

The N-terminal 178-amino-acid domain only of the SV40 large T antigen acts as a transforming suppressor of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

The Epstein-Barr virus nuclear antigen-1 may act as a transforming suppressor of the HER2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

Taxol stabilizes microtubules in mouse fibroblast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

Regulation of the G2/M transition by p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901235-X

7 January 2021

Identifiers

10.1016/S0006-291X(03)01235-X

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44533984&oldid=2027042811"